Close Menu

North America

The kit, developed by Gauss in collaboration with Cellex, uses a smartphone app to instruct an individual on how to collect a sample and perform the test.

The firm submitted its SARS-CoV-2 saliva test on its Pelican device to the US Food and Drug Administration for Emergency Use Authorization this week.

Executives mapped out the next few years for the firm, estimating a deceleration in COVID-19 testing beginning the second half of 2021.

In December, the firm was named a finalist in a $6 million Xprize competition to develop a rapid test for detecting SARS-CoV-2.

The company plans to publish new data on clinical sensitivity and specificity and has initiated multiple studies investigating new use cases.

The collaborators are requesting submissions including budget proposals to scale all supporting components of diagnostic test manufacturing.

DermTech said its gene expression-based Pigmented Lesion Assay for the early detection of melanoma is now available as an in-network option for BCBSTX members.

The PCR-based test, which is also now CE marked, provides a positive or negative result for each virus using a single specimen within three hours.

The organization also supported the recommendation to include $1.75 billion in funding for the US Centers for Disease Control and Prevention.

The firm's quarterly revenues beat estimates. Its full year revenues also beat estimates and were up 10 percent year over year.